Skip to content

Advertising disclosure: We earn commissions from some of the products we link to. It never changes our scores or what we publish. Read the full disclosure

Tom’s Weight LossRankings
Dietary supplementNot tested · not scored

NutraBloom Inositol Blend

A powder blending myo-inositol and D-chiro-inositol with grape seed extract and lycopene, at $21.99, aimed at polycystic ovary syndrome. Inositol has the most credible evidence of any supplement in this section for a specific clinical population, and combining both forms reflects how it has been studied. The problem is the framing: the page describes the product as treating and easing the symptoms of a diagnosed medical condition, which is not a claim a dietary supplement can make.

Last reviewed · researched from the manufacturer’s published pages by Tom

What’s in it

Amounts are shown only where the manufacturer publishes them. Anything without a figure is undisclosed — and for an active ingredient, an undisclosed dose is the central problem with this category.

  • Myo-inositolamount not published

    Described as a B-complex vitamin acting as a second messenger for several hormones; amount not published on the page we captured

  • D-chiro-inositolamount not published

    Described as supporting ovarian health; amount not published on the page we captured

  • Grape seed extractamount not published

    Antioxidant

  • Lycopeneamount not published

    Antioxidant

How the manufacturer says it works

NutraBloom states the blend combines myo-inositol, D-chiro-inositol and antioxidants that help decrease insulin resistance and re-establish normal menstrual cycles and ovulation, and that every ingredient is selected to ease and treat the symptoms of the condition.

What the evidence actually supports

Inositol is the strongest case in this section for a supplement with genuine clinical evidence in a defined population. Trials in PCOS have reported improvements in insulin sensitivity, menstrual regularity and ovulation, and myo-inositol combined with D-chiro-inositol — usually in a 40:1 ratio reflecting their physiological proportions — is the combination that has been studied. Including both forms rather than myo-inositol alone reflects that literature. PCOS is also strongly associated with insulin resistance, which is why the product sits adjacent to this category at all.

Where that evidence stops

Describing a supplement as treating a diagnosed condition is outside what dietary supplements may claim, and PCOS is a medical diagnosis that warrants clinical management rather than self-treatment — inositol is best used as part of that, not instead of it. No amounts are published for either inositol form, and the ratio between them is the single most important variable in the research; without it, the product cannot be compared against the trials. The antioxidants have no established role in PCOS outcomes. Inositol has nothing to do with GLP-1, and while it may help insulin resistance it is not a weight loss intervention. Anyone with PCOS considering it should be doing so alongside a clinician who knows their full picture.

Strengths and problems

Strengths

  • Inositol has the most credible clinical evidence of anything in this section, in a defined population
  • Combines both myo- and D-chiro-inositol, reflecting how the research was done
  • Describes the mechanism of each ingredient rather than making vague claims
  • Reasonably priced at $21.99

Problems

  • Describes itself as treating the symptoms of a diagnosed medical condition
  • No amounts published, and the myo- to D-chiro ratio is the key variable in the research
  • The antioxidants have no established role in PCOS outcomes
  • Nothing to do with GLP-1 or weight loss directly
  • Directions, warnings, testing and refund terms were not published on the page we captured

What the manufacturer publishes

Publishes 1 of 8 standard terms.

Intended use
Sold as a dietary supplement, though the page describes it in terms of easing and treating the symptoms of polycystic ovary syndrome.
Directions
Not publicly disclosed on the pages we captured.
Warnings
Not publicly disclosed on the pages we captured.
Allergens
Not publicly disclosed on the pages we captured.
Third-party testing
Not publicly disclosed on the pages we captured.
Pricing
$21.99 at capture.
Subscription
Not publicly disclosed on the pages we captured.
Refunds
Not publicly disclosed on the pages we captured.
Shipping
Not publicly disclosed on the pages we captured.

May suit

Someone with diagnosed PCOS discussing inositol with their clinician, who will ask for the amounts and the ratio before choosing a product.

Do not use if

  • You are self-treating suspected PCOS without a diagnosis — that needs a clinician
  • You are pregnant or trying to conceive without medical guidance — this affects ovulation
  • You take metformin or other insulin-sensitising medication without discussing it
  • You need to know the dose and ratio before buying

Frequently asked

Why does the ratio of the two inositols matter?

Because it is what the research is built on. Myo-inositol and D-chiro-inositol occur in human tissue at roughly a 40:1 ratio, and the PCOS trials that reported benefit generally used supplements matching it. Products deviating substantially from that have not been shown to work the same way, and some evidence suggests too much D-chiro-inositol may be counterproductive for ovarian function. Since this page publishes neither amount, the ratio is the first thing to ask about.

Is inositol a weight loss supplement?

No. Its evidence is in PCOS, where it appears to help insulin sensitivity, menstrual regularity and ovulation. Insulin resistance is connected to weight, so there is a plausible thread — but inositol has not been shown to produce meaningful weight loss and it has nothing to do with GLP-1. If you have PCOS, it is worth discussing with your clinician on its own merits.

Sources

Captured . Manufacturer pages change — check the current version before relying on anything.